ERYTHEMA MULTIFORME

Clinical trials for ERYTHEMA MULTIFORME explained in plain language.

Never miss a new study

Get alerted when new ERYTHEMA MULTIFORME trials appear

Sign up with your email to follow new studies for ERYTHEMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for rare skin condition: apremilast trial shows promise

Disease control Completed

This study tested a drug called apremilast (Otezla) in 8 people with chronic, treatment-resistant erythema multiforme, a painful skin and mucous membrane condition. The goal was to see if the drug could reduce the number and pain of flare-ups over 6 months. Participants took the …

Matched conditions: ERYTHEMA MULTIFORME

Phase: PHASE2 • Sponsor: Robert Micheletti • Aim: Disease control

Last updated May 15, 2026 11:53 UTC

ERYTHEMA MULTIFORME

Get alerted when new ERYTHEMA MULTIFORME trials appear

New hope for rare skin condition: apremilast trial shows promise